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The	herd	immunity	‘solution’	is	pub	economics	–	a
simple	model	that	won’t	work
Nicholas	Barr	(LSE)	argues	that	the	pursuit	of	herd	immunity	as	a	response	to	COVID-19	is	profoundly	mistaken.
The	error	is	no	accident,	but	an	example	of	a	much	wider	class	of	error	–	mistaking	a	simple	model	(which	can	be
useful	to	clarify	thinking)	for	a	good	enough	description	of	reality	to	be	used	as	the	basis	for	policy.
The	inappropriate	use	of	models	is	widespread,	and	leads	to	bad	policy.	The	models	implicated	in	the	financial
crisis	are	a	graphic	example.	A	more	recent	one	is	consideration	of	herd	immunity	as	a	way	of	tackling	COVID-19.
A	simple	model	of	herd	immunity
The	idea,	as	explained	more	fully	by	my	colleague	Bob	Hancké,	is	that	once	enough	people	have	been	exposed	to
the	virus	and	have	recovered	(the	example	later	in	this	article	uses	a	figure	of	75%),	there	are	not	enough	non-
immune	people	to	allow	the	virus	to	spread.
The	simple	model	of	herd	immunity	works	if:
a)	Infection	has	a	low	mortality	rate	across	all	age	groups	(so	that	large-scale	exposure	causes	few	deaths);
b)	Infection	causes	few	or	no	long-term	health	problems;
c)	A	person	who	recovers	has	long-term	immunity;	and
d)	The	healthcare	system	has	adequate	capacity	to	address	the	full	range	of	medical	conditions.
In	principle,	this	outcome	can	be	achieved	by	speedy	universal	rollout	of	a	vaccine	that	is	highly	effective	across	all
age	groups.
A	slightly	more	advanced	model	relaxes	assumption	(a),	so	that	there	is	an	age	gradient	in	mortality.	In	that	case,
the	simple	theory	holds	so	long	as
e)	The	at-risk	group	can	be	isolated	in	a	way	that	is	(i)	effective	and	(ii)	compatible	with	maintaining	mental	health.
Testing	the	assumptions
Cardiff	fans	celebrate	at	Wembley	in	2012.	Photo:	John	Candy	via	a	CC	BY	SA	2.0	licence
One	has	only	to	articulate	these	assumptions	to	see	how	far	they	deviate	from	reality.
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a)	There	is	overwhelming	evidence	of	a	steep	age-gradient	in	mortality	rates.
b)	There	is	growing	evidence	that	people	in	all	age	groups,	and	whether	or	not	they	have	a	pre-existing	condition,
suffer	continuing	health	problems	–	so-called	‘long	COVID’.	Women	in	their	50s	are	thought	to	be	at	greatest	risk.
c)	The	immune	status	of	people	who	have	been	infected	and	recovered	remains	the	subject	of	intense	research.
d)	In	the	UK	last	spring,	the	hospital	system	was	severely	stretched,	and	avoided	being	overwhelmed	only	by
pausing	large	numbers	of	non-COVID-related	investigations	and	procedures.	The	scale	of	the	problem	is	illustrated
by	what	are	known	as	excess	deaths,	i.e.	any	excess	in	the	number	of	deaths	in	a	month	relative	to	the	long-run
average	in	that	month	–	widely	regarded	as	the	best	single	measure.	Further	evidence	of	extra	non-COVID	deaths
is	the	recent	evidence	of	a	sharp	increase	in	the	numbers	of	people	dying	at	home.
e)	Shielding	a	large	at-risk	group	faces	multiple	problems.	First,	protection	is	difficult	even	in	a	formal	setting,	shown
by	the	large	number	of	excess	deaths	in	care	homes	earlier	in	the	year,	a	problem	that	has	not	gone	away.	Second,
many	at-risk	people	live	in	multi-generation	families	–	one	has	only	to	think	of	grandma	in	a	family	with	a	frontline
worker	who	mixes	with	the	public,	and/or	teenage	grandchildren,	who	mix	with	their	fellow	students.	Third,	even
where	it	is	possible	to	isolate	a	vulnerable	person	effectively,	the	cost	in	terms	of	mental	health	is	considerable	for
many	people	–	that	something	is	hard	to	quantify	does	not	mean	that	it	is	not	real	and	important.	The	problem	of
keeping	in	touch	with	relatives	in	care	homes	is	well	documented,	exemplified	by	poignant	pictures	of	people	trying
to	talk	through	closed	windows	to	elderly	relatives,	often	suffering	from	dementia.
Finally,	a	vaccine	that	is	highly	effective,	gives	immunity	for	a	significant	time,	and	is	available	on	a	scale	and	at	a
price	such	that	it	can	be	rolled	out	rapidly	universally	at	this	stage	remains	a	beguiling	vision.
The	moving	parts:	a	numerical	example
The	table	(spreadsheet	available	on	request)	illustrates	a	population	of	1	million,	a	death	rate	of	1%	and	a	target
that	75%	of	the	population	should	be	survivors	of	infection.
It	shows	that	in	a	simple	setting	with	a	1%	death	rate,	a	policy	of	herd	immunity	leads	to	approaching	half	a	million
deaths	(in	the	table,	the	number	(highlighted	in	D10)	is	488,722).
	 A B C D E
1 Number	infected	% 50 75 75.188 100
2 Absolute	number	infected 500,000 750,000 751,880 1,000,000
3 Number	of	deaths 5,000 7,500 7,518.80 10,000
4 Survivors	of	infection 495,000 742,500 744,361.20 990,000
5 Total	surviving	population 995,000 992,500 992,481.20 990,000
6 %	immune	survivors,	living	population 49.75 74.81 75 100
7 Immune,	%	of	original	population 49.5 74.25 74.44 99
8 Total	deaths
9 Deaths	per	million	population 7,500 7,518.8
10 Deaths	for	UK	population	(65m) 487,500 488,722
11 Extra	deaths	(Goodhart	effect)
12 Extra	deaths	per	million	population	(E3-D3) 18.8
13 Extra	deaths	for	UK	population	(65m) 1222
In	Column	C,	75%	of	the	initial	population	(row	1),	are	infected,	causing	750,000	infections	and	7500	deaths	(rows
2	and	3).	Because	of	those	deaths,	survivors	(row	4)	are	only	74.81%	of	the	total	surviving	population	(row	6),	so
that	more	people	need	to	be	infected	to	achieve	the	75%	target.	Two	effects	are	occurring,	going	in	opposite
directions:
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(i)	A	death	means	that	an	infection	does	not	result	in	an	immune	person,	requiring	an	extra	infected-and-then-
immune	person	to	fill	the	gap;
(ii)	But,	with	a	smaller	population,	fewer	people	in	absolute	terms	need	to	be	infected	to	reach	the	75%	ratio.
The	effect	of	(i)	is	larger	than	(ii)	because	the	target	for	herd	immunity	is	not	an	extra	immune	person	but	0.75	of	an
immune	person,	thus	complete	replacement	for	a	death	is	not	necessary.
The	target	of	75%	infected-and-survived	is	achieved	when	751,880	people	have	been	infected	(D2),	with	a	total	of
7518.8	deaths	(D3),	i.e.	18.8	people	more	than	in	the	first	pass	in	column	C.	Scaling	to	the	UK	population	(assumed
to	be	65	million),	the	pursuit	of	herd	immunity	leads	to	487,500	deaths	in	the	first	pass	(C10)	and	a	final	total	of
488,722	(D10),	i.e.	an	additional	1,222	extra	deaths	(D13)	because	of	the	need	to	compensate	for	the	deaths	in	the
first	pass.	Those	extra	deaths	are	an	example	of	Goodhart’s	Law,	explained	by	Bob	Hancké.
What	does	this	tell	us?
The	direct	conclusion	is	that,	even	if	the	assumptions	in	the	table	hold,	a	1%	death	rate	leads	to	nearly	half	a	million
deaths.	If	1%	is	on	over-estimate,	a	death	rate	of	half	of	that	leads	to	nearly	a	quarter	of	a	million	deaths.	However,
the	failure	of	the	assumptions	means	that	a	death	rate	of	1%	is	sadly	realistic;	and	even	if	the	75%	target	is
achieved	in	the	short	run,	without	extended	immunity,	either	natural	or	through	a	vaccine,	any	gains	will	be	short-
lived.	Many	people	(definitely	including	Bob	Hancké	and	me)	regard	the	resulting	deaths	on	anything	like	that	scale
as	immoral.
The	wider	point	is	that	it	is	a	fundamental	error	to	use	a	simple	model	in	a	complex	setting.	The	simple	herd
immunity	model	is	an	epidemiological	analogue	of	the	simple	model	of	a	market	economy	(what	economists	refer	to
as	a	‘first-best’	model),	which	assumes,	for	example,	that	all	consumers	are	well-informed	and	have	a	long-run
view,	and	that	all	firms	and	industries	are	perfectly	competitive	(the	formal	assumptions	are	set	out	in	the	Arrow-
Debreu	model).
The	simple	market	model	argues	for	consumer	choice.	But	consumers	of	complex	products	are	not	well-informed,
and	mistaken	choices	may	be	deeply	harmful.	For	precisely	that	reason	the	production	and	sale	of	pharmaceutical
drugs	are	heavily	regulated.	The	drive	for	that	regulation	was	the	string	of	deaths	from	patent	medicines	in	the	18th
and	19th	centuries.	We	do	not	need	to	learn	that	lesson	again.	As	my	book	on	the	welfare	state	explains,	a	central
reason	for	substantial	state	involvement	in	cash	benefits,	health	care	and	education	in	all	developed	and	middle-
income	countries	is	as	a	response	to	market	failure.
The	simple	herd	immunity	model,	like	the	simple	market	model,	is	useful	to	assist	clear	thinking,	but	to	use	either	as
a	basis	for	policy	is	an	example	of	what	I	have	called	‘pub	economics’	–	something	that	is	obviously	right,	and
everyone	knows	it’s	right	–	but	it’s	wrong.	In	both	cases,	proponents	make	the	mistake	of	believing	that	the	simple
model	is	the	whole	truth	rather	then	–	at	best	–	an	insight	into	part	of	the	truth.
The	fundamental	error,	in	short,	is	believing	that	the	model	is	a	good-enough	description	of	reality	to	work
well	in	a	policy	setting.	The	error	has	two	possible	roots:	either	people	genuinely	believe	that	the	model	is	an
adequate	description	of	reality,	or	their	technical	judgement	is	clouded	by	ideology.
Models	should	be	used,	not	abused.	As	the	economist	and	Nobel	prizewinner	Peter	Diamond	puts	it:
‘The	complexity	of	the	economy	calls	for	the	use	of	multiple	models	that	address	different	aspects.	.	.	.	I	am
concerned	that	.	.	.	too	many	economists	take	the	findings	of	individual	studies	literally	as	a	basis	for	policy	thinking,
rather	than	drawing	inferences	from	an	individual	study,	and	combining	them	with	inferences	from	other	studies	that
consider	other	aspects	of	a	policy	question,	as	well	as	with	intuitions	about	aspects	of	policy	that	have	not	been
formally	modelled.	Assumptions	that	are	satisfactory	for	basic	research,	for	clarifying	an	issue	by	isolating	it	from
other	effects,	should	not	play	a	central	role	in	policy	recommendations	if	those	assumptions	do	not	apply	to	the
world.	To	me,	taking	a	model	literally	is	not	taking	a	model	seriously.	It	is	worth	remembering	that	models	are
incomplete—indeed,	that	is	what	it	means	to	be	a	model‘	(emphasis	added).
This	post	represents	the	views	of	the	author	and	not	those	of	the	COVID-19	blog,	nor	LSE.	The	author	is	grateful	to
Bob	Hancké	for	helpful	comments	on	an	earlier	draft,	and	for	raising	the	subject	in	the	first	place,	generating	the
email	exchange	that	was	the	genesis	of	our	twin	articles.
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